The DOI matches its Crossref record.
Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus.
Open accessAbstract
A new affinity chromatography system that selectively retains glycosylated amino acids has been utilized to determine the amount of nonenzymatic glycosylation present in peripheral nerve from diabetic and control rats and dogs. The mean value for glycosylated amino acids in diabetic rats was 2.8 times greater than the mean value in normal rats (P less than 0.001). In diabetic dogs, mean values were 2.15 times greater than normal values (P less than 0.05). Amino acid analysis of reduced, glycosylated amino acids previously isolated by affinity chromatography showed that glycosylated lysine and its hydrolysis rearrangement products were the major borohydride-reducible adduct present. In addition, another glycosylated product was noted to be present in major proportions. This radioactive product did not chromatograph with any of the available glycosylated amino acid standards. The finding that diabetes results in a nearly 3-fold increase of peripheral nerve glycosylation is consistent with a number of previous investigations in which glycosylation was measured in hemoglobin, serum albumin, and urinary amino acids and peptides from diabetics and normals. The results reported here provide evidence that increased nonenzymatic glycosylation is occurring in a tissue where physiological, morphological, and clinical degeneration characteristically develop as a result of diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Advanced Glycation End Products and Diabetic Complications
Singh, V. P., Bali, A., Singh, N., & Jaggi, A. S. (2014) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2014.18.1.1 · Cited by 1,518
Duan, D., Goemans, N., Takeda, S., Mercuri, E., & Aartsma-Rus, A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00248-3 · Cited by 1,312
Nonenzymatic Glycosylation and the Pathogenesis of Diabetic Complications
BROWNLEE, M., VLASSARA, H., & CERAMI, A. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-4-527 · Cited by 1,007
Self-citationThe Role of Advanced Glycation End Products in Progression and Complications of Diabetes
Goh, S.-Y., & Cooper, M. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1817 · Cited by 987
Advanced glycation end products contribute to amyloidosis in Alzheimer disease
Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806
Self-citationBierhaus, A. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00233-2 · Cited by 555
Advanced Glycosylation: Chemistry, Biology, and Implications for Diabetes and Aging
Bucala, R., & Cerami, A. (1992) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60961-8 · Cited by 526
Self-citationKamalakkannan, N., & Prince, P. S. M. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_241.x · Cited by 522
Analysis of microtubule-associated protein tau glycation in paired helical filaments.
Ledesma, M. D., Bonay, P., Colaço, C., & Avila, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31849-5 · Cited by 333
Diabetes and Advanced Glycoxidation End Products
Huebschmann, A. G., Regensteiner, J. G., Vlassara, H., & Reusch, J. E. B. (2006) · Diabetes Care · doi:10.2337/dc05-2096 · Cited by 330
Self-citationBrown, M. J., & Asbury, A. K. (1984) · Annals of Neurology · doi:10.1002/ana.410150103 · Cited by 326
Vlassara, H., Brownlee, M., & Cerami, A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.17.5588 · Cited by 309
Self-citationGlucose and free radicals impair the antioxidant properties of serum albumin
BOURDON, E., LOREAU, N., & BLACHE, D. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.2.233 · Cited by 307
Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily
Bierhaus, A., Haslbeck, K.-M., Humpert, P. M., Liliensiek, B., Dehmer, T., Morcos, M., Sayed, A. A. R., Andrassy, M., Schiekofer, S., Schneider, J. G., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18058 · Cited by 299
Non-enzymatic glycosylation and the chronic complications of diabetes: an overview
Kennedy, L., & Baynes, J. W. (1984) · Diabetologia · doi:10.1007/bf00281113 · Cited by 299
Diabetic neuropathy and oxidative stress
Pop-Busui, R., Sima, A., & Stevens, M. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.625 · Cited by 286
Hypothesis: Glucose as a Mediator of Aging
Cerami, A. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb06319.x · Cited by 275
Self-citationImmunochemical approach to characterize advanced glycation end products of the Maillard reaction
Horiuchi, S., Araki, N., & Morino, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89449-6 · Cited by 272
Role of Advanced Glycation End Products and Their Receptors in Development of Diabetic Neuropathy
WADA, R., & YAGIHASHI, S. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1338.067 · Cited by 263
Free Radicals Generated during the Glycation Reaction of Amino Acids by Methylglyoxal
Yim, H.-S., Kang, S.-O., Hah, Y.-C., Chock, P. B., & Yim, M. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28228 · Cited by 260
Punithavathi, V. R., Prince, P. S. M., Kumar, R., & Selvakumari, J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.08.059 · Cited by 259
Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foods
Henle, T. (2005) · Amino Acids · doi:10.1007/s00726-005-0200-2 · Cited by 256
Experimental diabetic neuropathy: an update
Sima, A. A. F., & Sugimoto, K. (1999) · Diabetologia · doi:10.1007/s001250051227 · Cited by 253
Swaminathan, K., Kumar, S. M., Clemens, D. L., & Dey, A. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.05.022 · Cited by 21
Metadata
- Authors
- Vlassara, H., Brownlee, M., & Cerami, A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1981-08
- Volume
- 78
- Issue
- 8
- Pages
- 5190-5192
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1979744474
- Cited by
- 200
- References
- 0
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.